2004-2018年美国10个站点食源性疾病主动监测网络:非伤寒沙门菌感染患者临床结局与分离株耐药性的关联
研究将食源性疾病主动监测网络的流行病学数据与国家抗菌药物耐药性监测系统的非伤寒沙门菌耐药数据(2004-2018年)链接,分析耐药与住院、住院≥3天及死亡的关系。20%分离株(1105/5549)存在任何耐药,16%(469/2969)存在临床耐药。任何耐药与住院风险升高相关(校正OR 1.23,95%CI 1.04-1.46),临床耐药与较差结局无显著关联。
要点
- 任何耐药与住院风险升高相关(校正OR 1.23,95%CI 1.04-1.46)。
- 任何耐药组住院31% vs 无耐药组28%(P=.01),住院≥3天20% vs 16%(P=.01)。
- 临床耐药患者结局与无耐药者无显著差异。
核心结论
- 耐药病原体引起的非伤寒沙门菌感染与住院可能性存在显著关联。
- 临床耐药与较差结局无显著关联,提示治疗失败以外的因素(如菌株毒力、菌株来源、宿主因素)可能重要。
研究设计与样本
- 将食源性疾病主动监测网络的流行病学数据与国家抗菌药物耐药性监测系统的非伤寒沙门菌耐药数据(2004-2018年)链接。
- 任何耐药定义为对≥1种抗菌药物耐药;临床耐药定义为对氨苄西林、阿奇霉素、头孢曲松、环丙沙星或甲氧苄啶-磺胺甲噁唑耐药(限于全部5种药物均检测的分离株亚组)。
- 比较结局时校正年龄、州、种族/ ethnicity、国际旅行、暴发关联及分离株血清型和来源。
主要发现
- 20%分离株(1105/5549)存在任何耐药,16%(469/2969)存在临床耐药。
- 任何耐药组住院31% vs 无耐药组28%(P=.01);住院≥3天20% vs 16%(P=.01)。
- 死亡罕见,任何耐药组1.0% vs 无耐药组0.4%(P=.01)。
- 临床耐药患者结局与无耐药者无显著差异。
- 校正后任何耐药仍与住院显著相关(校正OR 1.23,95%CI 1.04-1.46)。
关键数值与推荐
- 任何耐药:对≥1种抗菌药物耐药。
- 临床耐药:对氨苄西林、阿奇霉素、头孢曲松、环丙沙星或甲氧苄啶-磺胺甲噁唑耐药(限于全部5种药物均检测的分离株亚组)。
- 任何耐药与住院的校正OR 1.23(95%CI 1.04-1.46)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nontyphoidal Salmonella causes an estimated 1.35 million US infections annually. Antimicrobial-resistant strains are a serious public health threat. We examined the association between resistance and the clinical outcomes of hospitalization, length-of-stay ≥3 days, and death. METHODS: We linked epidemiologic data from the Foodborne Diseases Active Surveillance Network with antimicrobial resistance data from the National Antimicrobial Resistance Monitoring System (NARMS) for nontyphoidal Salmonella infections from 2004 to 2018. We defined any resistance as resistance to ≥1 antimicrobial and clinical resistance as resistance to ampicillin, azithromycin, ceftriaxone, ciprofloxacin, or trimethoprim-sulfamethoxazole (for the subset of isolates tested for all 5 agents). We compared outcomes before and after adjusting for age, state, race/ethnicity, international travel, outbreak association, and isolate serotype and source. RESULTS: Twenty percent of isolates (1105/5549) had any resistance, and 16% (469/2969) had clinical resistance. Persons whose isolates had any resistance were more likely to be hospitalized (31% vs 28%, P = .01) or have length-of-stay ≥3 days (20% vs 16%, P = .01). Deaths were rare but more common among those with any than no resistance (1.0% vs 0.4%, P = .01). Outcomes for patients whose isolates had clinical resistance did not differ significantly from those with no resistance. After adjustment, any resistance (adjusted odds ratio 1.23, 95% confidence interval 1.04-1.46) remained significantly associated with hospitalization. CONCLUSIONS: We observed a significant association between nontyphoidal Salmonella infections caused by resistant pathogens and likelihood of hospitalization. Clinical resistance was not associated with poorer outcomes, suggesting that factors other than treatment failure (eg, strain virulence, strain source, host factors) may be important.
引用
- Francois Watkins LK, Luna S, Bruce BB, et al. Clinical Outcomes of Patients With Nontyphoidal Salmonella Infections by Isolate Resistance-Foodborne Diseases Active Surveillance Network, 10 US Sites, 2004-2018. Clin Infect Dis. 2024. PMID: 37823421. doi:10.1093/cid/ciad631
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。